These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8931496)
1. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain. Dev KK; Petersen V; Honoré T; Henley JM J Neurochem; 1996 Dec; 67(6):2609-12. PubMed ID: 8931496 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of [3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections. Nielsen EO; Johansen TH; Wätjen F; Drejer J J Neurochem; 1995 Sep; 65(3):1264-73. PubMed ID: 7543932 [TBL] [Abstract][Full Text] [Related]
4. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist. Kohara A; Okada M; Tsutsumi R; Ohno K; Takahashi M; Shimizu-Sasamata M; Shishikura J; Inami H; Sakamoto S; Yamaguchi T J Pharm Pharmacol; 1998 Jul; 50(7):795-801. PubMed ID: 9720630 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions. Petegnief V; Saura J; Dewar D; Cummins DJ; Dragunow M; Mahy N Neuroscience; 1999; 94(1):105-15. PubMed ID: 10613501 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain. Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ Br J Pharmacol; 1995 Oct; 116(3):2033-9. PubMed ID: 8640342 [TBL] [Abstract][Full Text] [Related]
7. AMPA- and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices. Jin S Neuropharmacology; 1997; 36(11-12):1503-10. PubMed ID: 9517420 [TBL] [Abstract][Full Text] [Related]
8. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites. Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632 [TBL] [Abstract][Full Text] [Related]
9. Autoradiographic characterization of the non-N-methyl-D-aspartate binding sites in human cerebellum using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione. Hatziefthimiou A; Mitsacos A; Kouvelas ED J Neurosci Res; 1994 Feb; 37(3):392-7. PubMed ID: 7909852 [TBL] [Abstract][Full Text] [Related]
10. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460 [TBL] [Abstract][Full Text] [Related]
11. Autoradiographic characterization of [3H]6-cyano-7-nitroquinoxaline-2,3-dione binding sites in adult chick brain. Zavitsanou K; Mitsacos A; Kouvelas ED Neuroscience; 1994 Oct; 62(3):955-62. PubMed ID: 7532837 [TBL] [Abstract][Full Text] [Related]
13. Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine. Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ Neuropharmacology; 1995 Apr; 34(4):405-10. PubMed ID: 7566471 [TBL] [Abstract][Full Text] [Related]
14. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists. Maj J; Rogóz Z; Skuza G; Jaros T Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504 [TBL] [Abstract][Full Text] [Related]
15. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029 [TBL] [Abstract][Full Text] [Related]
17. Effects of L-trans-pyrrolidine-2,4-dicarboxylate and L-threo-3-hydroxyaspartate on the binding of [3H]L-aspartate, [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), [3H]DL-(E)-2-amino-4-propyl-5-phosphono-3-pentenoate (CGP 39653), [3H]6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and [3H]kainate studied by autoradiography in rat forebrain. Balcar VJ; Li Y; Killinger S Neurochem Int; 1995 Feb; 26(2):155-64. PubMed ID: 7541266 [TBL] [Abstract][Full Text] [Related]
18. NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells. Yu W; Miller RF Brain Res; 1995 Sep; 692(1-2):190-4. PubMed ID: 8548303 [TBL] [Abstract][Full Text] [Related]
19. A unitary non-NMDA receptor short subunit from Xenopus: DNA cloning and expression. Ishimaru H; Kamboj R; Ambrosini A; Henley JM; Soloviev MM; Sudan H; Rossier J; Abutidze K; Rampersad V; Usherwood PN; Bateson AN; Barnard EA Recept Channels; 1996; 4(1):31-49. PubMed ID: 8723645 [TBL] [Abstract][Full Text] [Related]
20. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution. Randle JC; Guet T; Cordi A; Lepagnol JM Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]